NHS In The UK And The Cost-Benefit DilemmaNew research by health economists at the University of York has raised concerns over any move to broaden the range of costs and economic benefits considered in the analysis of new NHS treatments. A study by the University's Centre for Health Economics suggests that widening the perspective used by the National Institute for Health and Clinical Excellence (NICE) to assess the cost-effectiveness of new technologies may not benefit either the NHS or the wider economy. The research examined a range of possible policies and a number of case studies from past NICE appraisals...
Source: feedproxy.google.comWHO Rejects Accusations It Mishandled H1N1, Updates Worldwide StatsWHO spokesperson Gregory Hartl on Monday rejected accusations that the organization miscategorized H1N1 (swine flu) as a pandemic, calling such accusations "irresponsible," the Associated Press/Washington Post reports. "WHO also dismissed claims it colluded with drug companies to bring economic benefit to the industry by playing up the danger of the new H1N1 [swine flu] influenza strain," the news service writes. The organization is scheduled to meet Tuesday with the Parliamentary Assembly of the Council of Europe, "the watchdog body [that has] questioned whether the U.N...
Source: feedproxy.google.comAbbott Submits New HIV Test To FDA For Expedited ReviewAn assay to aid in the early detection of HIV infection may soon be available in the United States. Abbott announced today it has submitted a Premarket Approval application for the ARCHITECT HIV Ag/Ab Combo assay to the U.S. Food and Drug Administration (
FDA) for expedited review...
Source: feedproxy.google.comEuropean Commission Approves Orencia(R) (Abatacept) In Combination With Methotrexate For Children With Moderate To Severe pJIABristol-Myers Squibb Company (NYSE: BMY) announced that on 20 January 2010, the European Commission approved ORENCIA® (abatacept) in combination with methotrexate for the treatment of moderate to severe active polyarticular juvenile idiopathic arthritis (pJIA) in paediatric patients six years of age and older who have had an insufficient response to other DMARDS, including at least one TNF inhibitor.1 Disease-modifying treatment options for children with pJIA have been extremely limited to date...
Source: feedproxy.google.comDiabetes UK Needs YouWe are looking for more media volunteers to help us raise awareness of diabetes. A media volunteer is someone who is willing to be interviewed by a journalist. When there is a diabetes news story in the papers or on TV or radio, the story often includes an interview with a person with diabetes. The media likes to have a 'human face' to the story, somebody who the audience can relate to...
Source: feedproxy.google.comDoctors React To Recent Health Overhaul DevelopmentsSome doctors are already living in a post-health-reform world because of their own initiatives, including efforts to control costs and improve the quality of care, reports The (Riverside, Calif.) Press-Enterprise. "Models like [Dr. Alexander Terrazas' practice in Redlands], known as accountable care organizations, are among the options included in health care bills before the U.S. Senate and House of Representatives. They emphasize the need for patients to get more primary, preventive care to keep them out of more expensive specialists' offices and hospitals" (Hines, 1/24)...
Source: feedproxy.google.com
# posted by Network @ 11:29 AM
